PHARMAHUNGARY GROUP

Pharmahungary Group provides contract research with strong scientific support and offers early-stage novel technologies for out-licensing. Pharmahungary Group provides wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on but not limited to cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) metabolic diseases (diabetes, dyslipidemia, atherosclerosis, obesity, uremia, etc), renal, and inflammation indications with strong scientifi... c support Clinical R&D services focusing on full management of clinical trials with Medical Devices, Advanced Therapeutic Medicinal Products, Investigator Initiated Trials, and clinical trials that need strong regulatory & scientific support with e.g. sensitive patient population The company manages internal R&D projects to develop new technologies for out-licensing and co-development in the fields of diagnosis and therapy of cardiovascular and metabolic disease

#People #Financial #Website #More